Detalhe da pesquisa
1.
Machine learning identifies activation of RUNX/AP-1 as drivers of mesenchymal and fibrotic regulatory programs in gastric cancer.
Genome Res
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777607
2.
Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.
Liver Int
; 44(6): 1383-1395, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445848
3.
Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.
Gut
; 72(2): 226-241, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817555
4.
Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.
Gut
; 72(9): 1651-1663, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918265
5.
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.
Gut
; 71(7): 1277-1288, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433583
6.
The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study.
Clin Infect Dis
; 74(4): 575-583, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125883
7.
A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects.
Int J Cancer
; 151(3): 435-449, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35415893
8.
Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
J Hepatol
; 75(5): 1049-1057, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097994
9.
Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis.
Liver Int
; 41(12): 2849-2856, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592046
10.
HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men.
Liver Int
; 41(3): 482-493, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33305525
11.
Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study.
BMC Womens Health
; 21(1): 330, 2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34511082
12.
SMuRF: portable and accurate ensemble prediction of somatic mutations.
Bioinformatics
; 35(17): 3157-3159, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30649191
13.
The impact of SVR from direct-acting antiviral- and interferon-based treatments for HCV on hepatocellular carcinoma risk.
J Viral Hepat
; 27(8): 781-793, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187430
14.
Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies.
J Viral Hepat
; 27(3): 243-260, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664755
15.
Effects of Brazilian green propolis extract on planktonic cells and biofilms of multidrug-resistant strains of Klebsiella pneumoniae and Pseudomonas aeruginosa.
Biofouling
; 36(7): 834-845, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32954805
16.
Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations.
J Hepatol
; 71(6): 1116-1125, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433302
17.
Applying core theory and spatial analysis to identify hepatitis C virus infection "core areas" in British Columbia, Canada.
J Viral Hepat
; 26(3): 373-383, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447122
18.
The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
Liver Int
; 39(12): 2261-2272, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444846
19.
Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.
J Hepatol
; 69(5): 1007-1014, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142429
20.
Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk.
J Viral Hepat
; 25(12): 1481-1492, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30047609